Intercept Appoints Andrew Saik as Chief Financial Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Goldman warns high investor conviction could amplify volatility as sentiment shift
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Microsoft pulls out of UK data center deal with Nscale, Telegraph reports
- Lithuanians forced to take shelter after suspected drone enters airspace
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
- S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
Piper Sandler Positive on Intercept Pharmaceuticals (ICPT) Latest Hires
June 9, 2021 11:01 AM EDTPiper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $82.00 price target on Intercept Pharmaceuticals (NASDAQ: ICPT) after the company's latest hire - M. Michelle Berrey, M.D., M.P.H., as President of Research & Development and Chief Medical Officer. This follows... More



